Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Overview of attention for article published in Journal of Clinical Oncology, May 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
policy: 2 policy sources
twitter: 32 X users

patent: 19 patents
facebook: 4 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 534 Mendeley

So far, Altmetric has seen 39 X posts from 32 X users, with an upper bound of 177,811 followers.

@JCO_ASCO special article on @ASCO guidelines for endocrine therapy for hormone receptor +ve metastatic BrCa in today's #APaperADay. Barring immediately life-threatening disease, hormone therapy, alone/in combination, should be used as initial treatment…

Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. - PubMed - NCBI https://t.co/Zv5SoqtlAx

RT @gedefo_sefh: "Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: ASCO Guideline https://t.co/d0Xuw6EHfY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 35 additional X posts.